About this trial
The study topic investigates the potential advantages of low-flow anesthesia in terms of physiological protection and resource saving.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
being ASA1-2 status
between the ages of 18-70
who are planned for laparoscopic cholecystectomy
Disqualifiers
Patients who refuse to give informed consent
Pregnant and breastfeeding patients
Morbidly obese patients (Body mass index over 40)
Patients with uncontrolled diabetes mellitus, with serious cardiovascular, pulmonary, renal, hepatic disease, obstructive sleep apnea, with electrolyte imbalance- Those with a history of alcohol or drug abuse, with perioperative hemodynamic instability
Trial design
Parallel
Treatments tested in this trial
Sevoflurane (Volatile Anesthetic)
DeviceBoth groups will be given sevoflurane and one group will be given low current anesthesia and the other group will be given medium flow anesthesia.
low- medium flow anesthetic machine
DeviceThe study aims to compare the effects of low and normal flow sevoflurane anesthesia on the frontal QRS-T angle and cerebral oxygenation in laparoscopic cholecystectomy surgery.
Treatment groups
Trial outcomes
Primary outcomes
the effects of low-flow anesthesia on hemodynamic stability
The primary objective was to detect the adverse effects of low-flow anesthesia on hemodynamic stability and arrhythmia risk
Secondary outcomes
the cerebral oxygenation
The primary objective was to detect the adverse effects of low-flow anesthesia on cerebral oxygenation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: